The American Journal of Sports Medicine,
Год журнала:
2024,
Номер
52(13), С. 3212 - 3222
Опубликована: Окт. 12, 2024
Background:
Platelet-rich
plasma
(PRP)
is
increasingly
used
for
the
injection
treatment
of
knee
osteoarthritis
(OA).
However,
role
leukocytes
contained
in
PRP
controversial,
with
some
preclinical
studies
suggesting
detrimental
effects
and
others
emphasizing
their
contribution
secreting
bioactive
molecules.
Purpose:
To
compare
safety
effectiveness
leukocyte-rich
(LR-PRP)
leukocyte-poor
(LP-PRP)
OA.
Hypothesis:
That
could
influence
results
both
terms
adverse
events
clinical
outcomes.
Study
Design:
Randomized
controlled
trial;
Level
evidence,
1.
Methods:
This
double-blind
randomized
trial
included
132
patients
Kellgren-Lawrence
grade
1-3
OA
who
were
to
a
3-injection
cycle
either
LR-PRP
or
LP-PRP.
Patients
prospectively
assessed
at
baseline
2,
6,
12
months
subjective
evaluations
comprising
International
Knee
Documentation
Committee
(IKDC)
score,
KOOS
(Knee
injury
Osteoarthritis
Outcome
Score),
WOMAC
(Western
Ontario
McMaster
Universities
Index),
visual
analog
scale
pain,
EuroQol–visual
scale,
EuroQol–5
dimensions,
Tegner
activity
scale.
Objective
consisted
IKDC
objective
active/passive
range
motion,
circumference
index
contralateral
knees.
Patient
judgment
was
recorded
as
well
reactions
failures.
Results:
An
overall
improvement
outcomes
documented,
no
differences
between
2
groups,
except
score
months,
which
greater
group
compared
LP-PRP
(14.8
±
14.8
vs
8.6
13.3,
respectively;
P
=
.046),
active
(
.021)
passive
.040)
ROM
6
showing
statistically
significant
higher
values
group;
quadriceps
.042)
.045)
knees
significantly
group.
The
improved
from
42.5
17.6
55.6
21.4
<
.0005)
45.7
16.4
55.3
20.4
.001).
No
patient
observed
all
follow-up
time
points.
severe
related
reported,
but
mild
observed:
16
17
Treatment
failed
5
Conclusion:
demonstrated
that
did
not
affect
efficacy
intra-articular
injections
Both
comparable
points,
without
Registration:
NCT04187183
(ClinicalTrials.gov).
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Янв. 12, 2024
Abstract
Although
stem
cell-based
therapy
has
demonstrated
considerable
potential
to
manage
certain
diseases
more
successfully
than
conventional
surgery,
it
nevertheless
comes
with
inescapable
drawbacks
that
might
limit
its
clinical
translation.
Compared
cells,
cell-derived
exosomes
possess
numerous
advantages,
such
as
non-immunogenicity,
non-infusion
toxicity,
easy
access,
effortless
preservation,
and
freedom
from
tumorigenic
ethical
issues.
Exosomes
can
inherit
similar
therapeutic
effects
their
parental
cells
embryonic
adult
through
vertical
delivery
of
pluripotency
or
multipotency.
After
a
thorough
search
meticulous
dissection
relevant
literature
the
last
five
years,
we
present
this
comprehensive,
up-to-date,
specialty-specific
disease-oriented
review
highlight
surgical
application
exosomes.
derived
(e.g.,
embryonic,
induced
pluripotent,
hematopoietic,
mesenchymal,
neural,
endothelial
cells)
are
capable
treating
encountered
in
orthopedic
neurosurgery,
plastic
general
cardiothoracic
urology,
head
neck
ophthalmology,
obstetrics
gynecology.
The
diverse
cells-derived
hierarchical
translation
tissue-specific
responses,
cell-specific
molecular
signaling
pathways.
In
review,
viable
potent
alternative
managing
various
conditions.
We
recommend
future
research
combines
wisdoms
surgeons,
nanomedicine
practitioners,
cell
researchers
intriguing
area.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(5), С. 2767 - 2767
Опубликована: Март 2, 2022
Osteoarthritis
(OA)
is
a
common
degenerative
joint
disease
treated
mostly
symptomatically
before
approaching
its
definitive
treatment,
arthroplasty.
The
rapidly
growing
prevalence
of
OA
highlights
the
urgent
need
for
more
efficient
treatment
strategy
and
boosts
research
into
mechanisms
incidence
progression.
As
multifactorial
disease,
many
aspects
have
been
investigated
as
contributors
to
onset
Differences
in
gender
appear
play
role
natural
history
since
female
sex
known
increase
susceptibility
development.
aim
present
review
investigate
cues
associated
with
by
analyzing
various
hormonal,
anatomical,
molecular,
biomechanical
parameters,
well
their
differences
between
sexes.
Our
findings
reveal
possible
implications
progression
provide
evidence
gaps
current
state
art,
thus
suggesting
future
directions.
Osteoarthritis
(OA)
is
a
common
disease
that
endangers
millions
of
middle-aged
and
elderly
people
worldwide.
Researchers
from
different
fields
have
made
great
efforts
achieved
remarkable
progress
in
the
pathogenesis
treatment
OA.
However,
there
still
no
cure
for
In
this
review,
we
discuss
OA
summarize
current
clinical
therapies.
Moreover,
introduce
various
natural
synthetic
biomaterials
drug
release,
cartilage
transplantation,
joint
lubricant
during
treatment.
We
also
present
our
perspectives
insights
on
future.
hope
review
will
foster
communication
collaboration
among
biological,
clinical,
biomaterial
researchers,
paving
way
therapeutic
breakthroughs.
Abstract
Osteoarthritis
(OA),
a
chronic
degenerative
joint
disease,
is
highly
prevalent
among
the
aging
population,
and
often
leads
to
pain,
disability,
diminished
quality
of
life.
Although
considerable
research
has
been
conducted,
precise
molecular
mechanisms
propelling
OA
pathogenesis
continue
be
elusive,
thereby
impeding
development
effective
therapeutics.
Notably,
recent
studies
have
revealed
subchondral
bone
lesions
precede
cartilage
degeneration
in
early
stage
OA.
This
marked
by
escalated
osteoclast‐mediated
resorption,
subsequent
imbalances
metabolism,
accelerated
turnover,
decrease
volume,
contributing
significantly
pathological
changes.
While
role
hallmarks
extensively
elucidated
from
perspective
chondrocytes,
their
connection
with
osteoclasts
not
yet
fully
understood.
There
compelling
evidence
suggest
that
age‐related
abnormalities
such
as
epigenetic
alterations,
proteostasis
network
disruption,
cellular
senescence,
mitochondrial
dysfunction,
can
stimulate
osteoclast
activity.
review
intends
systematically
discuss
how
contribute
pathogenesis,
placing
particular
emphasis
on
age‐induced
shifts
It
also
aims
future
probing
into
therapeutic
approaches
targeting
during
aging.
Clinical Rheumatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 12, 2025
Osteoarthritis
knee
poses
a
substantial
and
pervasive
global
health
challenge.
The
data
was
extracted
from
the
Global
Burden
of
Disease
2021
Study
database.
First,
numbers
age-standardized
rates
(ASRs)
incidence,
prevalence,
disability-adjusted
life
years
(DALYs)
osteoarthritis
were
assessed
globally
by
sub-types
in
2021.
Subsequently,
we
employed
linear
regression
model
to
analyze
temporal
trends
1990
To
predict
future
burden,
utilized
age-period-cohort
Bayesian
model.
Furthermore,
conducted
sensitivity
analysis
using
Autoregressive
Integrated
Moving
Average
Exponential
Smoothing
In
2021,
accounted
for
30.85
million
incidence
cases,
374.74
prevalence
12.02
DALYs
cases
globally,
with
ASRs
353.67,
4294.27,
137.59,
respectively.
Females
individuals
over
50
old
identified
as
high-risk
populations,
while
higher
socio-demographic
index
regions
emerged
areas.
From
rose
14.13
million,
159.80
5.15
accompanied
increases
their
respective
ASRs.
Projections
APC
continued
increase
both
genders
until
2046.
Specifically,
male
are
projected
18.45
female
25.60
million.
Similarly,
rise
235.41
365.97
Male
expected
7.52
11.55
BAPC
models
also
indicate
an
upward
trend
number
cases.
conclusion,
represents
formidable
threat
public
health,
necessitating
development
proactive
tailored
strategic
interventions
that
account
global-specific
contexts.
Key
Points
•
populations.
Higher
disease
burden
attributable
increased
2019.
deaths
would
still
next
25
years.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Окт. 17, 2022
Osteoarthritis
(OA)
reduces
the
quality
of
life
as
a
result
pain
caused
by
continuous
joint
destruction.
Inactivated
Lactobacillus
(LA-1)
ameliorated
osteoarthritis
and
protected
cartilage
modulating
inflammation.
In
this
study,
we
evaluated
mechanism
which
live
LA-1
OA.
To
investigate
effect
on
OA
progression,
administered
into
monosodium
iodoacetate
(MIA)-induced
animals.
The
threshold,
damage,
inflammation
synovial
membrane
were
improved
LA-1.
Furthermore,
analysis
intestinal
tissues
feces
in
disease
model
has
been
shown
to
affect
systems
system
improve
microbiome
environment.
Interestingly,
tissue
was
reduced,
altered
Live
administration
led
an
increase
level
Faecalibacterium
is
short-chain
fatty
acid
(SCFA)
butyrate-producing
bacteria.
daily
supply
butyrate,
bacterial
SCFA,
showed
tendency
decrease
necroptosis,
type
abnormal
cell
death,
inducing
autophagy
reversing
impaired
inflammatory
These
results
suggest
that
modulated
changes
gut
microbiome,
suggesting
activation
can
reduce
aberrant
death.
summary,
or
butyrate
ameliorates
progression
environment
autophagic
flux.
Our
findings
regulation
microenvironment
therapeutic
target
for
Cells,
Год журнала:
2022,
Номер
11(24), С. 4034 - 4034
Опубликована: Дек. 13, 2022
Articular
cartilage
shows
limited
self-healing
ability
owing
to
its
low
cellularity
and
avascularity.
Untreated
defects
display
an
increased
propensity
degenerate,
leading
osteoarthritis
(OA).
During
OA
progression,
articular
chondrocytes
are
subjected
significant
alterations
in
gene
expression
phenotype,
including
a
shift
towards
hypertrophic-like
state
(with
the
of
collagen
type
X,
matrix
metalloproteinases-13,
alkaline
phosphatase)
analogous
what
eventuates
during
endochondral
ossification.
Present
management
strategies
focus,
however,
exclusively
on
inflammation
degradation.
A
better
understanding
hypertrophic
chondrocyte
phenotype
might
give
new
insights
into
pathogenesis,
suggesting
potential
disease-modifying
therapeutic
approaches.
Recent
developments
field
cellular/molecular
biology
tissue
engineering
proceeded
direction
contrasting
onset
this
but
knowledge
gaps
cause–effect
these
processes
still
present.
In
review
we
will
highlight
possible
advantages
drawbacks
using
approach
as
strategy
while
focusing
experimental
models
necessary
for
phenomenon.
Specifically,
discuss
brief
cellular
signaling
pathways
associated
with
progression
analyze
depth
disadvantages
various
that
have
been
used
mimic
it.
Afterwards,
present
developed
proposed
impede
hypertrophy
mineralization/calcification.
Finally,
examine
future
perspectives
strategies.
Asian Journal of Pharmaceutical Sciences,
Год журнала:
2023,
Номер
18(5), С. 100845 - 100845
Опубликована: Сен. 1, 2023
RNA
interference
(RNAi)
using
small
interfering
(siRNA)
has
shown
potential
as
a
therapeutic
option
for
the
treatment
of
arthritis
by
silencing
specific
genes.
However,
siRNA
delivery
faces
several
challenges,
including
stability,
targeting,
off-target
effects,
endosomal
escape,
immune
response
activation,
intravascular
degradation,
and
renal
clearance.
A
variety
nanotherapeutics
like
lipidic
nanoparticles,
liposomes,
polymeric
solid
lipid
nanoparticles
have
been
developed
to
improve
cellular
uptake,
protect
it
from
enhance
its
efficacy.
Researchers
are
also
investigating
chemical
modifications
bioconjugation
reduce
immunogenicity.
This
review
discusses
various
immune-mediated
diseases,
rheumatoid
arthritis,
osteoarthritis,
etc.
an
upsurge
interest
future
looks
promising
such
interdisciplinary
approach-based
modalities
that
combine
principles
molecular
biology,
nanotechnology,
formulation
sciences.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2024,
Номер
12
Опубликована: Янв. 16, 2024
Osteoarthritis
(OA),
as
a
degenerative
disease,
leads
to
high
socioeconomic
burdens
and
disability
rates.
The
knee
joint
is
typically
the
most
affected
characterized
by
progressive
destruction
of
articular
cartilage,
subchondral
bone
remodeling,
osteophyte
formation
synovial
inflammation.
current
management
OA
mainly
focuses
on
symptomatic
relief
does
not
help
slow
down
advancement
disease.
Recently,
mesenchymal
stem
cells
(MSCs)
their
exosomes
have
garnered
significant
attention
in
regenerative
therapy
tissue
engineering
areas.
Preclinical
studies
demonstrated
that
MSC-derived
(MSC-Exos),
bioactive
factor
carriers,
promising
results
cell-free
OA.
This
study
reviewed
application
various
MSC-Exos
for
treatment,
along
with
exploring
potential
underlying
mechanisms.
Moreover,
strategies
future
perspectives
utilization
engineered
MSC-Exos,
alongside
associated
challenges,
were
also
discussed.